Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹67Cr
IT Enabled Services/Business Process Outsourcing
Rev Gr TTM
Revenue Growth TTM
146.56%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

HGM
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 18.1 | 22.3 | 44.0 | 32.1 | 36.4 | 56.0 | 30.1 | 45.4 | 29.0 | 144.3 | 239.6 | 145.7 |
| 3 | 3 | 4 | 3 | 3 | 5 | 5 | 5 | 4 | 11 | 18 | 17 |
Operating Profit Operating ProfitCr |
| 16.0 | 14.8 | 16.3 | 16.3 | 19.2 | 16.5 | 15.9 | 14.7 | 18.5 | 17.5 | 5.7 | -16.9 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | -3 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
|
Growth YoY PAT Growth YoY% | 35.5 | -68.3 | -54.7 | 28.6 | -3.6 | 50.0 | 9.6 | 109.5 | 63.0 | 121.8 | -37.5 | -336.4 |
| 26.8 | 14.6 | 17.0 | 15.8 | 19.0 | 14.0 | 14.3 | 22.8 | 24.0 | 12.7 | 2.6 | -21.9 |
| 0.7 | 0.4 | 0.6 | 0.5 | 0.6 | 0.6 | 0.6 | 1.1 | 1.1 | 1.4 | 0.4 | -2.5 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | -7.6 | 1.9 | -11.9 | -22.5 | 4.0 | -12.0 | 4.2 | 19.9 | 33.8 | 39.4 | 132.9 |
| 18 | 15 | 15 | 13 | 10 | 9 | 7 | 8 | 10 | 13 | 19 | 50 |
Operating Profit Operating ProfitCr |
| -11.0 | 1.9 | 0.5 | 1.5 | 2.5 | 20.9 | 24.3 | 23.7 | 19.9 | 16.7 | 16.4 | 4.0 |
Other Income Other IncomeCr | 1 | 1 | 1 | 4 | 1 | 1 | 2 | 1 | 4 | 2 | 2 | 2 |
Interest Expense Interest ExpenseCr | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
Depreciation DepreciationCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| -3 | 0 | 0 | 3 | 1 | 2 | 3 | 3 | 5 | 4 | 5 | 2 |
| 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
|
| | 75.1 | -58.6 | 342.8 | -92.6 | 725.6 | 65.2 | -10.6 | 109.3 | -40.9 | 59.5 | -89.8 |
| -15.1 | -4.1 | -6.3 | 17.5 | 1.7 | 13.2 | 24.8 | 21.3 | 37.2 | 16.4 | 18.8 | 0.8 |
| -124.2 | -220.1 | -116.1 | 1.9 | 0.1 | 0.5 | 2.0 | 1.7 | 3.6 | 2.1 | 3.4 | 0.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
| 566 | 325 | 22 | 704 | 431 | 21 | 83 | 17 | 10 | 10 | 11 | 11 |
Current Liabilities Current LiabilitiesCr | 13 | 14 | 13 | 4 | 4 | 15 | 14 | 13 | 14 | 12 | 15 | 33 |
Non Current Liabilities Non Current LiabilitiesCr | 7 | 6 | 5 | 291 | 162 | 3 | 7 | 2 | 1 | 1 | 1 | 21 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 18 | 20 | 17 | 11 | 11 | 11 | 13 | 10 | 16 | 20 | 23 | 42 |
Non Current Assets Non Current AssetsCr | 580 | 338 | 35 | 1,000 | 599 | 41 | 104 | 35 | 22 | 16 | 16 | 36 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 3 | -3 | 2 | 0 | 2 | -3 | -1 |
Investing Cash Flow Investing Cash FlowCr | 1 | -10 | 1 | 1 | 2 | 4 | 2 |
Financing Cash Flow Financing Cash FlowCr | -1 | 8 | -2 | -2 | -1 | -1 | -1 |
|
Free Cash Flow Free Cash FlowCr | 3 | -3 | 2 | 0 | 2 | -3 | -1 |
| 1,524.9 | -180.4 | 69.8 | -5.2 | 48.9 | -129.2 | -29.7 |
CFO To EBITDA CFO To EBITDA% | 1,038.3 | -114.0 | 71.3 | -4.7 | 91.4 | -127.1 | -34.0 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 176 | 98 | 224 | 290 | 160 | 29 | 75 | 55 | 53 | 72 | 57 |
Price To Earnings Price To Earnings | 0.0 | -0.3 | 0.0 | 121.6 | 907.9 | 43.8 | 29.3 | 25.6 | 11.5 | 26.9 | 13.4 |
Price To Sales Price To Sales | 10.7 | 6.5 | 14.5 | 21.3 | 15.2 | 2.7 | 7.8 | 5.5 | 4.4 | 4.5 | 2.5 |
Price To Book Price To Book | 0.3 | 0.3 | 6.6 | 0.4 | 0.4 | 0.9 | 0.8 | 1.8 | 2.3 | 3.2 | 2.4 |
| -98.8 | 350.3 | 2,840.2 | 1,442.9 | 605.3 | 12.0 | 30.4 | 22.4 | 18.9 | 23.1 | 13.7 |
Profitability Ratios Profitability Ratios |
| 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| -11.0 | 1.9 | 0.5 | 1.5 | 2.5 | 20.9 | 24.3 | 23.7 | 19.9 | 16.7 | 16.4 |
| -15.1 | -4.1 | -6.3 | 17.5 | 1.7 | 13.2 | 24.8 | 21.3 | 37.2 | 16.4 | 18.8 |
| -0.4 | 0.1 | 0.5 | 0.5 | 0.1 | 8.3 | 3.3 | 9.4 | 23.4 | 15.8 | 19.5 |
| -0.4 | -0.2 | -2.9 | 0.3 | 0.0 | 4.3 | 2.5 | 7.2 | 19.9 | 11.6 | 17.6 |
| -0.4 | -0.2 | -1.9 | 0.2 | 0.0 | 2.8 | 2.0 | 4.7 | 11.9 | 7.4 | 10.7 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
HandsOn Global Management (HGM) Limited (NSE: **HOVS**), formerly known as **HOV Services Limited**, is an Indian-listed enterprise undergoing a strategic transformation into a global **AI-driven healthcare technology and services platform**. The company operates a hybrid model, combining direct **IT and IT-Enabled Services (ITeS)** with a portfolio of strategic investments in the North American, APAC, and Middle East markets.
---
### **Strategic Pivot: The AI-First Healthcare Roadmap**
HGM has aggressively reoriented its business model toward high-margin, tech-enabled healthcare delivery. The company’s vision is to integrate **Agentic AI workflow solutions** with specialized human expertise to address inefficiencies in global healthcare systems.
* **Autonomous Medical Coding:** Through the acquisition of **Aidéo Technologies**, HGM has integrated the **Gemini™ AI Coding Platform**. This platform utilizes **Large Language Models (LLMs)** and **Natural Language Processing (NLP)** to automate medical coding, reducing human error and accelerating the billing cycle.
* **Revenue Cycle Management (RCM):** The company is scaling its RCM vertical to provide end-to-end financial management for healthcare providers, focusing on improving collection rates and reducing claim denials.
* **Healthcare Analytics & Ambient Listening:** HGM is developing virtual scribe services and clinical data management tools. These "ambient listening" technologies aim to improve provider efficiency by capturing patient-doctor interactions and converting them into structured clinical data.
* **Interoperability Standards:** The company’s platforms are designed to be **HL7-compliant**, ensuring seamless integration with industry-standard **Electronic Health Records (EHR)** systems.
---
### **Corporate Structure & Global Footprint**
HGM manages its international operations through a streamlined network of subsidiaries, primarily focused on the US market.
| Entity | Relationship | Location | Role / Status |
| :--- | :--- | :--- | :--- |
| **HOVS LLC** | Wholly Owned Subsidiary | USA | **Material Subsidiary**; primary investment vehicle. |
| **Healthcare Capital Holding LLC** | Wholly Owned Subsidiary | USA | Incorporated **May 2025**; dedicated to healthcare M&A. |
| **Aidéo Technologies LLC** | Step-down Subsidiary | USA | Acquired **Sept 2025**; core AI autonomous coding arm. |
| **HCI LLC** | Subsidiary | Cayman Islands | Established for operational harmonization and global scaling. |
| **HOV Environment LLC** | Subsidiary | USA | **Discontinued operations**; slated for closure. |
| **HOV Environment Solutions Pvt Ltd** | Step-down Subsidiary | India | Indian arm of the discontinued environment unit. |
**Rationalization Initiatives:**
* **Demerger:** In **August 2025**, the Board gave in-principle approval for the demerger of **HOVS LLC** (Delaware), pending final **RBI** approval.
* **Entity Dissolution:** **HOVS Holdings Limited (Hong Kong)** was dissolved on **May 16, 2025**, as part of a broader effort to eliminate non-operational layers.
---
### **Investment Portfolio & Related Party Ecosystem**
A significant portion of HGM’s value resides in its strategic holdings and long-term service contracts with affiliated global entities.
* **Exela Technologies, Inc. (NASDAQ: XELA):** HGM holds a significant interest in Exela. In **November 2024**, HOVS LLC exchanged **55%** of its **Preferred A Stock** for **Common Stock**. However, as of **September 2025**, the fair value was marked at **Rs. Nil** following Exela's delisting from Nasdaq.
* **High-Value Service Contracts (FY 2026-27 Targets):**
* **HealthAxis Group LLC:** Services contract valued at **US$ 8.70 Million (₹ 78.30 Crore)**.
* **XBP Europe Limited:** Services contract valued at **US$ 6 Million**.
* **SourceHOV LLC & HOVG LLC:** Ongoing IT support and data entry contracts, valued at **₹ 50 Crore** in FY 2024-25.
---
### **Financial Performance & Capital Allocation**
HGM maintains a **debt-free** standalone balance sheet, prioritizing liquidity and internal accruals to fund its inorganic growth strategy.
**Consolidated Financial Highlights:**
| Metric (INR Crore) | FY 2023-24 | FY 2022-23 |
| :--- | :--- | :--- |
| **Total Income** | **17.85** | **15.87** |
| **Profit from Continuing Operations** | **2.65** | **4.48** |
| **Total Comprehensive Income/(Loss)** | **(2.40)** | **(12.66)** |
| **Basic & Diluted EPS (Total)** | **₹ 2.13** | **₹ 3.63** |
| **Debt to Total Equity Ratio** | **0.42** | **0.51** |
* **Revenue Model:** Driven almost exclusively by the **export of services**. Foreign exchange earnings for FY 2023-24 were **₹ 16.12 Crore**.
* **Asset Monetization:** The company generates steady cash flow from leasing building space in Pune, with future rental receivables of **₹ 4.61 Crore** projected through 2028.
* **Capital Issuance:** In **November 2025**, the company issued **1,449,275 units** of **Class B Preferred Stock** (valued at **₹ 8.88 Crore**) to former members of Aidéo Technologies to facilitate business expansion.
---
### **Operational Infrastructure & Human Capital**
* **Global Hubs:** Primary operational centers are located in **Pune, India** and **Las Vegas, USA**.
* **Leadership:** The appointment of **Dr. Bhargav Thakkar** as **EVP - Healthcare Services** in **July 2025** signals a commitment to clinical-grade AI integration.
* **Labor Compliance:** The company recognized a non-material provision in **December 2025** in anticipation of the new **Indian Labour Codes** (Code on Social Security, 2020).
---
### **Risk Management Framework**
HGM operates under a structured risk mitigation strategy focused on the following pillars:
* **Currency Volatility:** With a substantial portion of revenue in **USD** and costs in **INR**, the company manages an open exposure of approximately **$993,000 (₹ 82.78 Million)** through continuous market tracking.
* **Credit & Default Risk:** Financial assets are strictly categorized; receivables are written off if payments are more than **one year past due**.
* **Operational Inflation:** To combat rising **minimum wages** and **attrition**, HGM is shifting from labor-intensive BPO to **AI-led automation** to reduce manpower dependence.
* **Cyber Security:** Mitigation includes **multi-layered anti-hacking systems**, regular **patch management**, and disaster recovery systems across global locations.
* **Investment Volatility:** The company’s exposure to quoted shares (e.g., Exela) subjects the balance sheet to market fluctuations, managed via **Fair Value through Other Comprehensive Income (FVOCI)** accounting.